Safety of synthetic cannabidiol as a novel food pursuant to Regulation (EU) 2015/2283
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was…
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was…
Abstract This study evaluated the comparative plasma pharmacokinetics of two oral CBD formulations—oil-based (5 mg/kg) and treat-mixed (50 mg)—in dogs…
Abstract Context: As a naturally occurring terpenoid found in Cannabis sativa L. (Cannabaceae), cannabidiol (CBD) has gained public and industry…
Abstract Cannabinoids offer a novel pharmacotherapeutic approach and can complement other medications to address unmet clinical needs in numerous patients,…
Abstract Background: An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and…
Abstract Background and purpose: Around 30% of patients with epilepsy show drug‐resistant epilepsy (DRE). While cannabidiol has demonstrated efficacy as…
Abstract Background: Cannabis is the most common illicit substance used in pregnancy. As use continues to increase, understanding peoples’ behaviors…
Abstract Abstract: Objectives: The use of cannabis-based medicine (CBM) as a therapeutic has surged in Australia over the past 5…
Abstract Cannabis is an herb known for its significant pharmacological effects. This study evaluated the safety of a female sexual…
Abstract Cannabidiol (CBD)-containing products are widely commercially available for companion animals, mirroring popularity in human use. Although data on the…